How it possible with all of the positive trials we have had and positive data we expect that Missling can’t find a PR worthy enough to release? For example it would have been nice for him to say that we have had guidance from the FDA. The conversations were very positive and they have requested an additional number of patients to be enrolled in our Excellence trial necessary for it to be pivotal. Or something to that affect. Or maybe we don’t have it in the bag yet so to speak as some here might think.
Market Data 
Markets 
AI
